Comparing the Vitreous Floaters Functional Questionnaire to the VFQ-25 in Vision Degrading Myodesopsia from Vitreous Floaters

HIGHLIGHTS

  • •

    The Vitreous Floaters Functional Questionnaire (VFFQ) is a validated PRO that quantifies the impact of vision degrading myodesopsia from vitreous floaters on visual quality-of-life.

  • •

    The VFFQ correlates strongly with vitreous density, measured by quantitative ultrasonography, and contrast sensitivity.

  • •

    193 subjects with floaters completed both the VFFQ and the NEI VFQ-25.

  • •

    The dynamic range (potential = 0 to 100) of the VFFQ was 22 to 92, which was greater than the VFQ-25 (64 to 100).

  • •

    Patients who chose observation had considerably higher VFFQ composite scores than those who chose limited refractive vitrectomy (73.0 ± 9.9 vs. 53.9 ± 11.4; p <.0001), but the VFQ-25 composite scores were similar in both groups (79.1 ± 6.0 vs. 77.3 ± 5.1; P =.053).

  • •

    VFFQ had a better predictive value than VFQ-25 in identifying patients who elected limited refractive vitrectomy as well as those electing observation.

  • •

    After limited refractive vitrectomy, the VFFQ improved 72.2 ± 3.2% ( P <.001), while VFQ-25 only improved 7.4% ± 1.8% (average of post-op months 6, 12, 24, and 36).

Purpose

To compare the Vitreous Floater Functional Questionnaire (VFFQ-23) to the NEI Visual Function Questionnaire (VFQ-25) in patients with vision degrading myodesopsia (VDM) from vitreous floaters. Composite scores for each questionnaire were compared in asymptomatic controls, patients who chose observation (OBS), and those electing vitrectomy. The impact of limited refractive vitrectomy (LRV) on the composite scores of each questionnaire was determined.

Design

A retrospective study comparing questionnaire correlations with management choice (OBS or LRV), and a prospective, non-randomized, interventional case series.

Subjects

74 subjects were asymptomatic controls; 193 subjects had bilateral floaters: 139 chose OBS, 54 elected LRV surgery.

Methods

Patients complaining of bilateral “ floaters ” completed the VFFQ-23 and VFQ-25 questionnaires and composite scores were correlated with visual acuity (VA), contrast sensitivity (CS), quantitative ultrasonography (QUS), and management choice (OBS or LRV). LRV was performed in 54 patients, and all tests were repeated at 6, 12, 24, and 36 months post-operatively.

Main Outcome Measures

VFFQ-23 (0 to 100), NEI VFQ-25 (0 to 100), VA (Snellen), CS (Freiburg Acuity Contrast Test), QUS (AU), predictive value, Receiver Operator Characteristic areas under the curve (AUC), decision curve analysis (DCA).

Results

VFFQ-23 correlated with CS ( R = −.619; P <.0001) and QUS ( R = −.632; P <.0001). VFFQ-23 correctly identified 89% of patients who chose LRV with a positive predictive value of 73.8% for LRV and 95.3% for OBS, while VFQ-25 had a positive predictive value of only 60%; VFFQ-23 AUC = 0.923, VFQ-25 AUC = 0.570. DCA demonstrated a higher net benefit for VFFQ-23 than both “Treat All” and “Treat None” strategies. After LRV, VFFQ-23 improved 72.2% ± 3.2% ( P <.001), while VFQ-25 only improved 7.4% ± 1.8%, ( P <.001). The difference-in-differences before and after surgery between VFFQ-23 and VFQ-25 was 31.9 ± 12.0 ( P <.001).

Conclusions

In patients with vitreous floaters, the VFFQ-23 correlated with CS and QUS. VFFQ-23 was a better predictor of patient management choice (OBS or LRV) and was more sensitive to post-operative improvement than VFQ-25. VFFQ-23 superiority to VFQ-25 was confirmed by DCA. Thus, VFFQ-23 may be more useful in assessing the subjective impact of floaters on visual quality-of-life, in screening/triage, and as an outcome measure of current and future therapies for VDM.

INTRODUCTION

F loaters are hair- or fly-like obscurations in vision at times appearing as cobwebs, but occasionally having a “glass noodle” appearance due to remnants of fetal blood vessels. , Studies have found that vitreous floaters can significantly impact visual quality-of-life (QoL). ,,, Posterior vitreous detachment (PVD) is the most common etiology of vitreous floaters in older individuals, ,,,, while the most common cause in younger people is myopic vitreopathy, ,, where fibrous liquefaction with aggregation of collagen fibrils and PVD occur earlier in life. ,,,

Patients complaining of bothersome vitreous floaters usually have degradation in contrast sensitivity (CS) ,,,, that correlates with increased vitreous density as measured by quantitative ultrasonography (QUS). , Since QUS has recently been shown to correlate with vitreous light scattering, this test is an accurate clinical surrogate for measuring light scattering in vivo . The term “ Vision Degrading Myodesopsia ” (VDM) refers to clinically significant cases which are diagnosed on the basis of these objective quantitative metrics. , However, since people have varying perceptions of disturbances to their health it is difficult to accurately determine the impact of VDM from vitreous floaters on QoL based solely upon a patient’s history. This impediment may have colored the experience of some ophthalmologists to regard patient complaints of vitreous floaters as overblown.

Recently, an informative method of assessing subjective patient disturbance from vitreous floaters was developed and validated, called the Vitreous Floaters Functional Questionnaire (VFFQ-23). The present study was undertaken to compare the VFFQ-23 to the NEI Visual Function Questionnaire (VFQ-25) , in terms of the relative correlations of the 2 questionnaires with vision (visual acuity (VA) and CS), vitreous structure assessed by quantitative ultrasonography, and patient management choice (observation (OBS) vs. limited refractive vitrectomy (LRV)). Questionnaire findings in the LRV group quantified Q-o-L changes post-operatively. Since the VFFQ-23 is specifically designed to evaluate floaters and the VFQ-25 assesses general vision, it is hypothesized that the VFFQ-23 will be superior to the VFQ-25 in several, if not all, of these comparisons.

METHODS

This study was conducted in patients with bilateral symptomatic vitreous floaters evaluated at the VMR Institute for Vitreous Macula Retina in Huntington Beach, California (JS). Institutional Review Board (IRB) approval was granted by the Providence St. Joseph Hospital IRB and written informed consent was obtained from each subject. This study adhered to the principles of the Health Insurance Portability and Accountability Act (HIPAA) and was conducted in accordance with the ethical principles of the Declaration of Helsinki.

Correlations between the questionnaires and visual function (VA and CS) and vitreous structure (QUS) were evaluated retrospectively. Changes in the composite scores of the 2 questionnaires in patients who underwent LRV surgery were analyzed prospectively.

SUBJECTS

The study population for retrospective analyses consisted of all patients who presented to the VMR Institute for Vitreous Macula Retina in Huntington Beach, California between 2013 and 2024 with the chief complaint of bilateral “floaters”, met the inclusion/exclusion criteria, and who completed both questionnaires at study entry. For the prospective analyses, operated patients had to be evaluated with all testing prior to any intervention, had to have undergone bilateral (on separate occasions) limited refractive vitrectomy (JS), and completed both questionnaires at study entry as well as on 4 subsequent occasions over a 3-year post-op period to be included in the study. Meeting these criteria were 193 subjects (99 males and 94 females; age range 19 to 95 years) with a subjective duration of floaters prior to study entry = 57.9 +/- 68.7 months. Exclusion criteria were exudative maculopathy, diabetic retinopathy, glaucoma, retinal detachment, keratopathy, or any co-morbidities that could affect contrast sensitivity or alter vitreous structure. Patients with a history of YAG laser vitreolysis or vitrectomy (for any related or unrelated condition(s)) were excluded. Patients with multifocal intraocular lenses were excluded due to potential effects on contrast sensitivity. There were 74 asymptomatic control subjects (39 males and 35 females) who completed both questionnaires and underwent contrast sensitivity testing as well as quantitative ultrasonography. Repeatability was tested in 24 OBS subjects who had all testing done on 3 separate occasions: study entry, 1 year, and 2 years later.

Patients electing LRV underwent sutureless 25-gauge pars plana vitrectomy (Constellation, Alcon, Fort Worth, Texas) performed under local anesthesia, as previously described. ,,, In cases where the posterior vitreous was still attached to the fundus, PVD was not intentionally induced to reduce the risk of iatrogenic retinal breaks and detachment, ,,, as well as to minimize post-operative elevation of intravitreal oxygen levels that can promote cataractogenesis. In phakic patients, 3-4 mm of retrolental vitreous was left intact to further mitigate cataract formation. ,,,

CLINICAL TESTING

Since all experimental subjects had bilateral floaters, the results of visual function testing and vitreous structure assessments with ultrasound were averaged for the 2 eyes and results presented per subject (see tables and graphs).

Visual Function Tests

Best corrected visual acuity (VA) was measured using a standard backlit ETDRS chart. Contrast sensitivity (CS) was measured as previously described. ,,,,,,, After dark adapting, patients were tested in a dark room on a LED computer monitor using the open-source software, Freiburg Visual Acuity and Contrast Test (FrACT; https://michaelbach.de/fract/ ). ,, FrACT uses psychometric methods combined with anti-aliasing and dithering using an 8-position tumbling Landolt C with varying levels of contrast sensitivity to provide an accurate thresholding assessment of contrast sensitivity. Screen size and testing distance (2.9 meters from stimulus) were measured and calibrated to the software settings. Results are reported as the Weber threshold: % W e b e r ( % W ) = 100 × L u m i n a n c e m a x − L u m i n a n c e m i n L u m i n a n c e m a x

Vitreous Structure Assessment

Ultrasonography was performed to diagnose the presence of PVD and quantify vitreous echodensity, as previously described. ,,,,,,,, A clinical ophthalmic ultrasound system (AVISO, Quantel Medical, Clermont-Ferrand, France) with a customized 15-MHz single-element transducer, a 6-dB bandwidth extending from 9.5 to 20 MHz, a 20-mm focal length, and a 7-mm aperture acquired 100 total frames at 16 frames/second. QUS processing was performed on the frames devoid of artefacts in the same manner as previously described. – ,,,, Analyses generated 3 parameters: the sum of the square of the acoustic values within the central/posterior vitreous divided by the area of measurement (“ energy ”, E); the percentage of the central/posterior vitreous filled by echogenic clusters greater than 50 pixels or 0.069 mm (“ P50 ”); and the mean of the acoustic values divided by the area of the central/posterior measurement area (“ mean ”, M). As previously described, – ,,,, a composite of these 3 parameters was calculated as:

QUS composite index = [ 1 / 2 E + ( M x 10 ) + ( P 50 × 100 ) ] A r b i t r a r y U n i t s ( A U )

Patient Reported Outcome (PRO) Measures

Self-administered questionnaires were completed by each patient before any clinical testing. Each questionnaire’s composite score ranged from 0 to 100, with higher scores indicating greater visual satisfaction and better perceived visual QoL.

National Eye Institute Visual Function Questionnaire (VFQ-25)

The NEI VFQ-25 is a self-administered questionnaire designed to measure the influence of visual disability and visual symptoms on general health domains. , It consists of 25 questions assessing the impact of visual impairment on various aspects of daily life. The NEI VFQ-25 is commonly used in research to evaluate outcomes of treatments for eye diseases such as glaucoma, , cataracts, , and macular degeneration. Respondents rate their visual function and the degree to which vision problems affect their well-being, subjective visual experience, and vision-related overall Q-o-L. The VFQ-25 composite score was calculated using established scoring guidelines. ,,

Vitreous Floater Functional Questionnaire (VFFQ-23)

The VFFQ-23 is a 23-item, self-administered questionnaire developed as a PRO measure to assess how vitreous floaters affect daily visual activities. Every item includes the word “floaters” to ensure the focus remains solely on floater-related symptoms. Refined using Rasch analysis, the VFFQ-23 is unidimensional, locally independent, and well-targeted to the floater patient population. VFFQ-23 composite scores were calculated based on a Rasch-calibrated analysis as previously described.

STATISTICAL ANALYSES

Multiple variable logistic regression analysis (SPSS; IBM) was used to determine differences in demographics (gender: male or female) and clinical findings (myopia, PVD, lens status) between OBS and LRV groups. Test-retest reliability was determined using single-measurement, absolute-agreement, 2-way, mixed-effects intraclass correlation coefficient analyses (SPSS, IBM). Two sample t-tests were used to determine differences in quantitative values of age, CS, QUS, VFFQ-23, and VFQ-25 composite scores between OBS and LRV subjects. Pearson’s correlation analyses evaluated the relationship between the 2 questionnaires (VFFQ-23 and VFQ-25) as well as between each questionnaire and VA, CS, and QUS. In patients undergoing LRV, a paired t-test compared pre-operative CS, QUS, VFFQ-23, and VFQ-25 to post-operative measures at 6, 12, 24, and 36 months. In subjects who had bilateral LRV, post-operative evaluations were performed only after both eyes underwent surgery. The differences between the 2 questionnaires with respect to the changes in post-operative findings were evaluated using difference-in-differences calculations.

To evaluate the relative ability of the 2 questionnaires to predict a patient’s management choice (OBS vs. LRV), sensitivity, specificity, positive predictive value (PPV), negative predictive value, and accuracy were calculated using standard definitions. , A receiver operating characteristic (ROC) curve was generated to illustrate the trade-off between sensitivity and specificity of the questionnaire composite scores in distinguishing patients who chose OBS from those electing LRV surgery. Accuracy calculations were used to explore cutoff values of each questionnaire composite score vis à vis the likelihood of surgery. Lastly, to evaluate potential clinical usefulness in identifying patients likely to elect surgery, Decision Curve Analyses (DCA) were performed across a range of clinically relevant threshold probabilities as previously described. , DCA incorporates the trade-off between true positives and false positives and provides a more comprehensive assessment of net clinical benefit than positive predictive value alone. The analyses included calculation of the VFFQ-23 predictive value using a logistic regression model with a dichotomous outcome (limited refractive vitrectomy vs. observation), as described by Vickers and colleagues. ,

RESULTS

SUBJECT DEMOGRAPHICS AND CLINICAL CHARACTERISTICS

Table 1 presents demographics and clinical characteristics of the study population. Asymptomatic controls were approximately the same age as subjects who elected OBS, and those who underwent LRV, while LRV subjects were 15% older than OBS subjects ( P <.0001). Logistic regression analysis found no differences in gender ( P =.319) or prevalence of myopia (greater than 3 diopters; P =.549). LRV subjects had a 23% higher prevalence of PVD than OBS (Odds Ratio = 2.29, 95% CI: 1.25–4.19, P =.008), and a 35% greater prevalence of pseudophakia (Odds Ratio = 6.76, 95% CI: 3.74–12.23, P <.001). In pseudophakic subjects, the prevalence of posterior capsulotomy was not statistically significant between the LRV and OBS groups ( P =.129).

Table 1

Subject Demographics and Ocular Characteristics.

Controls ( n = 74) LRV ( n = 54
108 Eyes)
OBS ( n = 139
278 Eyes)
P
LRV vs. OBS
Age (years) 54.6 ± 11.3 60.9 ± 11.8 53.0 ± 16.0 .0001
Sex 39 ♂ 35 ♀ 27 ♂ 27 ♀ 72 ♂ 67 ♀ .8730
Lens Status 67/ 74 (91%) phakic 60/108 (56%) phakic 253/278 (91%) phakic .0001
Myopia 22/ 74 (30%) 56/108 (52%) myopic 165 myopic (59%) .353
PVD Status 29/ 75 (39%) PVD 89/108 (82%) PVD 161/278 (59%) PVD .0001

There were no differences between subjects choosing OBS or those electing LRV with respect to gender or myopia (defined as–3 Diopters or more). Subjects choosing OBS were younger, more often phakic, and had a lower prevalence of PVD, confirming previous studies.

PVD– Posterior Vitreous Detachment (determined by ultrasonography).

LRV– limited refractive vitrectomy.

OBS– observation group.

CLINICAL TESTING AND PRO MEASURES

Repeat testing over 2 years after study entry found high test-retest reliability in 48 eyes of 24 OBS subjects: intraclass correlation coefficient for CS was 0.922 (95% CI: 0.875–0.954), for QUS was 0.861 (95% CI: 0.776–0.917), and for VFFQ-23 was 0.863 (95% CI: 0.732–0.936). In the entire study group (including controls), there was no correlation between the 2 questionnaire composite scores ( R = 0.104; P =.899). There was also no correlation between each questionnaire and VA (VFFQ-23: R = −0.039 P =.526; VFQ-25: R = −0.012; P =.845). In 74 asymptomatic controls, vitreous echodensity was 17.5% lower than OBS subjects ( P <.0001), and 54% less than LRV subjects ( P <.0001). CS was also 29% better in asymptomatic controls than OBS subjects ( P <.0001) and 54% better than LRV subjects ( P <.0001). The VFFQ-23 composite scores reflected this, averaging 13% better in asymptomatic controls than OBS subjects ( P <.0001) and 53% better than LRV subjects ( P <.0001; Table 2 ).

Table 2

Clinical Tests and Patient Reported Outcome Measures.

Clinical Test CTRL
( n = 74;
148 Eyes)
OBS
( n = 139; 278 Eyes)
LRV
( n = 54;
108 Eyes)
Contrast Sensitivity (CS)
(% Weber Threshold) *
2.06 ± 0.60 2.89 ± 1.38 4.49 ± 1.49
Quantitative Ultrasonography
(QUS, AU) *
566 ± 97 686 ± 176 1237 ± 352
Visual Function Questionnaire (VFQ-25) 82.8 ± 6.3 79.1 ± 6.0 77.3 ± 5.1
Vitreous Floaters Functional Questionnaire (VFFQ-23) 82.2 ± 7.7 73.0 ± 9.9 53.9 ± 11.4
Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 20, 2026 | Posted by in OPHTHALMOLOGY | Comments Off on Comparing the Vitreous Floaters Functional Questionnaire to the VFQ-25 in Vision Degrading Myodesopsia from Vitreous Floaters

Full access? Get Clinical Tree

Get Clinical Tree app for offline access